Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Vertex patents new series with strong and specific p38 kinase-inhibitory activity

Feb. 17, 1999

Phase III trial data support leflunomide as useful RA treatment option

Feb. 16, 1999

IL-1beta inhibitors from ADIR useful for inflammatory conditions

Feb. 16, 1999

Imidazole cytokine-suppressive antiinflammatory compounds from SB

Feb. 16, 1999

Mechanism of action of T-614 in RA examined in vitro

Feb. 15, 1999

SmithKline Beecham claims new series of inhibitors of cytokine production

Feb. 15, 1999

Novel NOS inhibitors prepared at Astra, claimed for use in inflammatory disorders

Feb. 15, 1999

Celebrex receives approval in Mexico

Feb. 12, 1999

New antiinflammatory/immunomodulatory compounds from Signal act at a transcriptional level

Feb. 12, 1999

Synvisc relieves pain, delays need for total knee replacement in osteoarthritis

Feb. 12, 1999

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...